New drug NS-079 tested in healthy people for first time
Knowledge-focused
Not yet recruiting
This early-phase trial will test the safety and how the body processes a new drug called NS-079 in 78 healthy adults aged 18 to 55. Participants will receive either NS-079 or a placebo, and some will also take paroxetine to check for drug interactions. The study aims to gather ba…
Phase: PHASE1 • Sponsor: NeuShen Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC